Generation of a CRISPR activation mouse that enables modelling of aggressive lymphoma and interrogation of venetoclax resistance
Article in Nature Communications (August 2022)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
A Novel Nanomedicine System TAR-AuNSs/Dox for the Treatment of Drug-Resistant Lymphoma
Article in Journal of Nanomaterials (April 2022)
Adrenal intravascular large B-cell lymphoma: report of 1 case and review of literature
Article in Journal of Leukemia and Lymphoma (March 2022)